Trial intelligence / Profile preview

Sofosbuvir Regimens in HCV Genotype 3

NCT02576314Phase 3Completed

Sponsor
Humanity & Health Research Centre
Start
May 2015
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sofosbuvir in hepatitis C virus infection, sponsored by Humanity & Health Research Centre. Started May 2015; status: completed.

02

Drugs

sofosbuvir
03

Conditions

hepatitis C virus infection

Beyond the preview

Go deeper on NCT02576314.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02576314.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call